image
Frontline Ltd. FRO
Energy - Oil & Gas Midstream - NYSE - BM
Watchlist
$ 14.29
11.4 %
$ 3.18 B
Market Cap
6.41
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FRO stock under the worst case scenario is HIDDEN Compared to the current market price of 14.3 USD, Frontline Ltd. is HIDDEN

FRO Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FRO stock under the base case scenario is HIDDEN Compared to the current market price of 14.3 USD, Frontline Ltd. is HIDDEN

FRO Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FRO stock under the best case scenario is HIDDEN Compared to the current market price of 14.3 USD, Frontline Ltd. is HIDDEN

FRO Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart FRO

image
1M -18%
6M -48%
1Y -48%
3Y 121%
5Y 107%
All
$23.0$23.0$22.0$22.0$21.0$21.0$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
2.05 B REVENUE
13.77%
Growth Rates
1Year 13.77%
3Years 39.87%
5Years 16.45%
7Years 17.93%
10Years 13.86%
782 M OPERATING INCOME
4.69%
Growth Rates
1Year 4.69%
3Years 196.96%
5Years 26.69%
7Years 29.12%
10Years 33.58%
496 M NET INCOME
-24.50%
Growth Rates
1Year -24.50%
3Years 259.48%
5Years 28.77%
7Years 21.35%
10Years 17.19%
736 M OPERATING CASH FLOW
-13.99%
Growth Rates
1Year -13.99%
3Years 127.03%
5Years 21.32%
7Years 28.73%
10Years 30.01%
-483 M INVESTING CASH FLOW
60.87%
Growth Rates
1Year 60.87%
3Years -10.01%
5Years -20.46%
7Years 5.58%
10Years -36.96%
-148 M FINANCING CASH FLOW
-34.13%
Growth Rates
1Year -34.13%
3Years -18.43%
5Years -53.22%
7Years -3.78%
10Years -8.59%
426 M REVENUE
-13.19%
Growth Rates
1Year 13.77%
3Years 39.87%
5Years 16.45%
7Years 17.93%
10Years 13.86%
130 M OPERATING INCOME
-10.42%
Growth Rates
1Year 4.69%
3Years 196.96%
5Years 26.69%
7Years 29.12%
10Years 33.58%
66.7 M NET INCOME
10.38%
Growth Rates
1Year -24.50%
3Years 259.48%
5Years 28.77%
7Years 21.35%
10Years 17.19%
168 M OPERATING CASH FLOW
2.00%
Growth Rates
1Year -13.99%
3Years 127.03%
5Years 21.32%
7Years 28.73%
10Years 30.01%
45.2 M INVESTING CASH FLOW
1956.16%
Growth Rates
1Year 60.87%
3Years -10.01%
5Years -20.46%
7Years 5.58%
10Years -36.96%
-120 M FINANCING CASH FLOW
39.95%
Growth Rates
1Year -34.13%
3Years -18.43%
5Years -53.22%
7Years -3.78%
10Years -8.59%
Balance Sheet Frontline Ltd.
image
Current Assets 826 M
Cash & Short-Term Investments 418 M
Receivables 0
Other Current Assets 408 M
Non-Current Assets 5.39 B
Long-Term Investments 11.8 M
PP&E 5.25 B
Other Non-Current Assets 135 M
6.71 %6.57 %84.36 %Total Assets$6.2b
Current Liabilities 596 M
Accounts Payable 0
Short-Term Debt 461 M
Other Current Liabilities 134 M
Non-Current Liabilities 3.28 B
Long-Term Debt 3.28 B
Other Non-Current Liabilities 452 K
11.89 %3.46 %84.64 %Total Liabilities$3.9b
EFFICIENCY
Earnings Waterfall Frontline Ltd.
image
Revenue 2.05 B
Cost Of Revenue 1.01 B
Gross Profit 1.04 B
Operating Expenses 263 M
Operating Income 782 M
Other Expenses 286 M
Net Income 496 M
3b3b2b2b2b2b1b1b500m500m002b(1b)1b(263m)782m(286m)496mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
50.95% GROSS MARGIN
50.95%
Averages
1Year 50.95%
3Years 42.55%
5Years 35.14%
7Years 30.99%
10Years 30.70%
38.13% OPERATING MARGIN
38.13%
Averages
1Year 38.13%
3Years 36.84%
5Years 31.22%
7Years 27.46%
10Years 24.80%
24.17% NET MARGIN
24.17%
Averages
1Year 24.17%
3Years 31.28%
5Years 25.23%
7Years 19.95%
10Years 14.79%
21.17% ROE
21.17%
Averages
1Year 21.17%
3Years 23.65%
5Years 19.18%
7Years 14.92%
10Years 10.06%
7.97% ROA
7.97%
Averages
1Year 7.97%
3Years 9.69%
5Years 7.87%
7Years 6.12%
10Years 4.37%
12.65% ROIC
12.65%
Averages
1Year 12.65%
3Years 11.72%
5Years 9.94%
7Years 8.47%
10Years 6.92%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Frontline Ltd.
image
100m100m00(100m)(100m)(200m)(200m)(300m)(300m)(400m)(400m)(500m)(500m)(600m)(600m)(700m)(700m)(800m)(800m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 496 M
Depreciation & Amortization 339 M
Capital Expenditures -915 M
Stock-Based Compensation 0
Change in Working Capital 0
Others -98.2 M
Free Cash Flow -179 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Frontline Ltd.
image
Wall Street analysts predict an average 1-year price target for FRO of $22.5 , with forecasts ranging from a low of $12.5 to a high of $30 .
FRO Lowest Price Target Wall Street Target
12.5 USD -12.60%
FRO Average Price Target Wall Street Target
22.5 USD 57.43%
FRO Highest Price Target Wall Street Target
30 USD 109.94%
Price
Max Price Target
Min Price Target
Average Price Target
3030282826262424222220201818161614141212May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
2.40% DIVIDEND YIELD
0.2 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
3.003.002.502.502.002.001.501.501.001.000.500.500.000.000.350.150.41.070.370.20.40.150.70.70.620.20.50.150.80.620.251.200.10.900.11.350.32.870.341.950.200.000.000.00201520152016201620172017201920192020202020222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 4
6. Ownership
Insider Ownership Frontline Ltd.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
All You Need to Know About Frontline (FRO) Rating Upgrade to Strong Buy Frontline (FRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 2 weeks ago
New Strong Buy Stocks for April 4th FRO, ESE, TKOMY, FUTU and SGHC have been added to the Zacks Rank #1 (Strong Buy) List on April 4, 2025. zacks.com - 2 weeks ago
Best Income Stocks to Buy for April 4th HSNGY, FRO and TEF made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 4, 2025. zacks.com - 2 weeks ago
Best Value Stocks to Buy for April 4th FRO, SCGLY and APTV made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 4, 2025. zacks.com - 2 weeks ago
Best Income Stocks to Buy for April 1st FRO, IX and UVSP made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 1, 2025. zacks.com - 2 weeks ago
Best Value Stocks to Buy for April 1st FRO, SAN and IX made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 1, 2025. zacks.com - 2 weeks ago
Should Value Investors Buy FRONTLINE PLC (FRO) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 weeks ago
Are Investors Undervaluing FRONTLINE PLC (FRO) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
Actinium Pharmaceuticals Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly Diagnosed AML Represents first ever triplet combination using targeted radiotherapy as a backbone therapy in AML with initial clinical data expected in 2H:2025 Expansion into frontline setting greatly expands potential addressable patient opportunity for Actimab-A Triplet combination supported by previously completed Phase 1 trials of Actimab-A + Venetoclax and Actimab-A + CLAG-M demonstrating Actimab-A's mutation agnostic and synergistic potential NEW YORK , March 11, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that the first clinical trial under its previously announced Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for Actimab-A has been initiated. The trial (NCT06802523) will evaluate the triplet combination comprised of Actimab-A, Venetoclax (Abbvie/Roche) an oral Bcl-2 inhibitor and ASTX-727 (Taiho Oncology, an Otsuka holdings company) a novel oral hypomethylating agent (HMA) in frontline acute myeloid leukemia (AML) patients. prnewswire.com - 1 month ago
3 Shipping Stocks Worth Betting on Despite Industry Headwinds Following a careful analysis of the Zacks Transportation Shipping industry, we advise betting on stocks like FRO, FLNG and GOGL. zacks.com - 1 month ago
Win-Win Momentum Plays With Strong Dividend Yields Whether deserved or not, dividend stocks have a reputation for being somewhat boring—sturdy and dependable, but in low-growth industries or comprising companies that are well beyond their days of rapid share price gains. Though dividend stocks are not necessarily safe in all cases, they have a reputation for being a strong defensive play. marketbeat.com - 1 month ago
Frontline Plc (FRO) Q4 2024 Earnings Call Transcript Frontline Plc (NYSE:FRO ) Q4 2024 Earnings Conference Call February 28, 2025 9:00 AM ET Company Participants Lars Barstad - Chief Executive Officer Inger Klemp - Chief Financial Officer Conference Call Participants Jonathan Chappell - Evercore ISI Omar Nokta - Jefferies Sherif Elmaghrabi - BTIG Lars Barstad Thank you very much, dear all, and thank you for dialing into Frontline's quarterly earnings call. Being in the tanker industry, one is used to evolving and ever changing markets, largely affected by geopolitical events, but it's becoming a little bit exhausting having potential seismic shifts by the hour. seekingalpha.com - 1 month ago
8. Profile Summary

Frontline Ltd. FRO

image
COUNTRY BM
INDUSTRY Oil & Gas Midstream
MARKET CAP $ 3.18 B
Dividend Yield 2.40%
Description Frontline Ltd., a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2021, the company operated a fleet of 70 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Hamilton, Bermuda.
Contact Par-la-Ville Place, Hamilton, HM 08 https://www.frontline.bm
IPO Date Aug. 6, 2001
Employees 88
Officers Marios Saveriades Secretary Mr. Lars H. Barstad Chief Executive Officer of Frontline Management AS Ms. Inger Marie Klemp Chief Financial Officer of Frontline Management AS